Christopher Winrow
Company: Cyclerion Therapeutics
Job title: Head of Translational Medicine
Seminars:
Leading the Vanguard – Early Clinical Assessment of Biomarkers to Drive Development of Alzheimer’s Disease Therapies 2:30 pm
Building a translational strategy to identify robust preclinical signals Interrogating biomarkers by applying a translational pharmacology approach in Phase 1 Capitalizing on objective assessments to guide clinical development in early patient studiesRead more
day: Day Two
Live Q&A With Your Expert Speakers 3:00 pm
day: Day Two